Solara Active Pharma Sciences Limited (NSE:SOLARA)
486.70
-12.90 (-2.58%)
Feb 16, 2026, 11:50 AM IST
NSE:SOLARA Revenue
Solara Active Pharma Sciences had revenue of 3.49B INR in the quarter ending December 31, 2025, with 16.21% growth. This brings the company's revenue in the last twelve months to 12.55B, down -4.23% year-over-year. In the fiscal year ending March 31, 2025, Solara Active Pharma Sciences had annual revenue of 12.84B, down -0.40%.
Revenue (ttm)
12.55B
Revenue Growth
-4.23%
P/S Ratio
1.92
Revenue / Employee
7.07M
Employees
1,775
Market Cap
24.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 12.84B | -51.60M | -0.40% |
| Mar 31, 2024 | 12.89B | -1.55B | -10.73% |
| Mar 31, 2023 | 14.44B | 1.75B | 13.83% |
| Mar 31, 2022 | 12.68B | -3.49B | -21.56% |
| Mar 31, 2021 | 16.17B | 2.95B | 22.33% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aarti Pharmalabs | 18.01B |
| Indoco Remedies | 17.60B |
| Innova Captab | 14.97B |
| Windlas Biotech | 8.68B |
| Orchid Pharma | 8.11B |
| RPG Life Sciences | 6.74B |
| Ind-Swift Laboratories | 5.94B |
| Beta Drugs | 3.86B |
Solara Active Pharma Sciences News
- 9 days ago - Solara Active Pharma Sciences Ltd (BOM:541540) Q3 2026 Earnings Call Highlights: Strategic ... - GuruFocus
- 9 days ago - Q3 2026 Solara Active Pharma Sciences Ltd Earnings Call Transcript - GuruFocus
- 3 months ago - Solara Active Pharma’s Mangalore facility clears US FDA inspection with VAI classification - Business Upturn
- 3 months ago - Solara Active Pharma Sciences Ltd (BOM:541540) Q2 2026 Earnings Call Highlights: Navigating ... - GuruFocus
- 3 months ago - Q2 2026 Solara Active Pharma Sciences Ltd Earnings Call Transcript - GuruFocus
- 3 months ago - Solara Active Pharma shares slump nearly 9% today after reporting Q2 net loss - Business Upturn
- 10 months ago - Solara Active Pharma shares rise 4% after Ambernath facility clears USFDA inspection with zero observations - Business Upturn
- 1 year ago - Solara Active Pharma shares down 5% as Managing Director Poorvank Purohit resigns - Business Upturn